The BRAF Mutation Analysis V600E Test is a specialized diagnostic procedure aimed at detecting the V600E mutation within the BRAF gene. This mutation is significant because it is frequently associated with various types of cancer, including melanoma, thyroid cancer, and colorectal cancer. Identifying the presence of this mutation can help in tailoring the most effective treatment strategies for patients, as it often indicates responsiveness to specific targeted therapies.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, this test offers a reliable means of genetic analysis. The process involves collecting a sample of the patient's tissue or blood, which is then subjected to sophisticated molecular techniques to scrutinize the BRAF gene for the specific V600E mutation.
The cost of the BRAF Mutation Analysis V600E Test at DNA Labs UAE is 1800 AED. This price reflects the intricate technology and expertise required to accurately identify this genetic variation. For patients and healthcare providers, the test represents a crucial step in the journey towards personalized medicine, enabling more precise and effective cancer treatment plans based on an individual's genetic makeup.
The "CALR Mutation Analysis Deletion or Insertion in Exon 9 Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect specific mutations within exon 9 of the CALR gene. These mutations are primarily associated with certain types of blood disorders, including myeloproliferative neoplasms (MPNs) like essential thrombocythemia (ET) and primary myelofibrosis (PMF). The test specifically looks for deletions or insertions within this region of the CALR gene, which can have significant implications for disease prognosis and treatment strategies.
Performed in a state-of-the-art laboratory setting, this analysis involves extracting DNA from a patient's blood sample and employing sophisticated molecular techniques to scrutinize the exon 9 of the CALR gene for any aberrations. Identifying the presence of these mutations is crucial for confirming the diagnosis, aiding in risk stratification, and guiding the selection of appropriate therapeutic approaches.
The cost of the "CALR Mutation Analysis Deletion or Insertion in Exon 9 Test" at DNA Labs UAE is set at 1800 AED. This investment covers the comprehensive testing process, from sample collection to detailed genetic analysis, ensuring accurate and reliable results. Patients undergoing this test can expect a thorough examination of their CALR gene status, providing essential insights into their condition and facilitating personalized medical care.
The CCND1 Test is a specialized diagnostic procedure designed to identify alterations in the CCND1 gene, which can have significant implications for understanding various medical conditions, including certain types of cancers. This gene plays a crucial role in cell cycle regulation, and its abnormal expression or mutation can lead to uncontrolled cell growth, a hallmark of cancerous transformations. By analyzing the CCND1 gene, healthcare professionals can gain valuable insights into the molecular underpinnings of a patient's condition, guiding treatment decisions and prognostic assessments.
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test ensures accuracy and reliability in results, employing state-of-the-art technology and methodologies. The cost of the CCND1 Test at DNA Labs UAE is set at 1800 AED, reflecting the intricate processes and expertise required to accurately detect and interpret genetic variations in the CCND1 gene. Patients undergoing this test can expect a comprehensive analysis, contributing to a more personalized and effective approach to their healthcare management.
The CEBPA Full Gene Mutation Analysis Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CEBPA gene. This gene plays a critical role in the development and function of certain types of white blood cells, and mutations in CEBPA are associated with an increased risk of developing acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow.
The test involves a detailed examination of the CEBPA gene to detect any abnormalities or mutations. It is particularly useful for patients who have been diagnosed with AML, as the presence of CEBPA mutations can influence treatment decisions and prognosis. The test can also be used for individuals with a family history of AML or related blood disorders, as part of a comprehensive genetic assessment.
Performed at the state-of-the-art facilities of DNA Labs UAE, the CEBPA Full Gene Mutation Analysis Test is conducted by a team of experienced geneticists and laboratory technicians. The cost of the test is 1800 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the CEBPA gene.
For patients and families facing the challenges of AML, this test offers valuable insights into the genetic factors influencing the disease, enabling more personalized and effective treatment strategies.
Chromosome Breakage Syndrome Test, offered by DNA Labs UAE, is a specialized diagnostic procedure aimed at identifying chromosomal abnormalities that predispose individuals to various genetic disorders. This test is particularly vital for detecting conditions characterized by an increased susceptibility to chromosome breakage, which can lead to cancer, developmental delays, and other severe health issues. At a cost of 1800 AED, the test involves analyzing the individual's DNA to identify any anomalies in chromosome structure or function that could indicate the presence of a chromosome breakage syndrome, such as Fanconi anemia or Bloom syndrome. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test provides crucial insights into the genetic health of an individual, facilitating early intervention and personalized medical strategies to manage or mitigate the impact of these genetic disorders.
The C-Myc Oncogene Test is a specialized diagnostic procedure designed to detect abnormalities in the MYC gene, which is often implicated in the development of various types of cancer. The MYC gene plays a crucial role in cell growth, division, and apoptosis; hence, its dysregulation can lead to uncontrolled cell proliferation, a hallmark of cancer. This test is particularly useful for identifying specific genetic mutations associated with the MYC oncogene, providing critical information that can influence treatment decisions and prognosis.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers precise and reliable results. With state-of-the-art technology and a team of experienced professionals, DNA Labs UAE ensures the highest standards of accuracy and confidentiality in testing.
The cost of the C-Myc Oncogene Test at DNA Labs UAE is 1800 AED. This investment in health can be invaluable for patients at risk of cancers associated with the MYC oncogene, enabling early detection and potentially more effective treatment options. It's important for patients to consult with their healthcare provider to understand the implications of the test results and the best course of action based on those results.
The Erythropoietin Receptor Gene Mutation Analysis Test is a specialized diagnostic procedure designed to identify mutations in the gene that encodes the erythropoietin receptor (EPOR). This receptor plays a crucial role in the regulation of red blood cell production in the body. Mutations in the EPOR gene can lead to various hematological disorders, including erythrocytosis, which is characterized by an abnormal increase in the number of red blood cells, potentially leading to complications such as blood clots, stroke, and heart attack.
Conducted at DNA Labs UAE, this test offers a comprehensive analysis to detect any genetic alterations in the erythropoietin receptor gene, aiding in the accurate diagnosis and management of conditions associated with EPOR mutations. The test is particularly valuable for individuals presenting symptoms of erythrocytosis, those with a family history of hematological disorders, or as part of a broader genetic investigation.
Priced at 1800 AED, the Erythropoietin Receptor Gene Mutation Analysis Test is accessible for patients seeking advanced genetic testing services in the UAE. The cost reflects the sophisticated technology and expertise required to perform this intricate analysis. By choosing DNA Labs UAE, patients can expect precise results, which are crucial for the development of targeted treatment strategies, ultimately improving patient outcomes in managing conditions related to EPOR gene mutations.
The FGFR1 Solid Tumor Test is a specialized diagnostic examination designed to detect alterations in the Fibroblast Growth Factor Receptor 1 (FGFR1) gene, which can be indicative of various solid tumors. This test is particularly significant in the realm of personalized medicine, as FGFR1 gene mutations or amplifications are associated with a range of cancers, including breast, lung, and bladder cancers, among others. Identifying such genetic abnormalities can guide oncologists in tailoring targeted therapies for patients, enhancing treatment efficacy and potentially improving outcomes.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test utilizes advanced genomic technologies to analyze tumor DNA for FGFR1 abnormalities. The cost of the FGFR1 Solid Tumor Test is set at 1800 AED, reflecting the comprehensive analysis and detailed reporting provided. By opting for this test, patients and healthcare providers can access critical genetic information that may unlock personalized treatment pathways, contributing to more effective cancer care strategies.
The FOXO1 Break Apart FISH (Fluorescence In Situ Hybridization) Alveolar Rhabdomyosarcoma Diagnostic Test is a highly specialized laboratory test designed to detect genetic abnormalities associated with alveolar rhabdomyosarcoma (ARMS), a type of cancer that primarily affects muscle tissue. This test focuses on identifying the disruption or "break apart" of the FOXO1 gene, which is a hallmark of ARMS. The presence of such genetic rearrangements can help in confirming a diagnosis of alveolar rhabdomyosarcoma, thereby enabling healthcare providers to tailor treatment plans more effectively.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs the FISH technique to visualize and map the genetic material within a patient's cells. This method allows for the precise detection of genetic translocations involving the FOXO1 gene, which are critical for diagnosing ARMS. The cost of the FOXO1 Break Apart FISH Alveolar Rhabdomyosarcoma Diagnostic Test is 1800 AED, reflecting the advanced technology and expertise required to conduct this specialized diagnostic procedure.
By providing a clear genetic profile of the tumor, this test plays a crucial role in the management of alveolar rhabdomyosarcoma, guiding decisions regarding the most appropriate and effective treatment strategies.
The "Chromosomes 13, 18, 21, X, and Y Test" is a specialized genetic screening conducted at DNA Labs UAE, designed to detect chromosomal abnormalities related to these specific chromosomes. This test plays a crucial role in diagnosing conditions such as Down syndrome (Trisomy 21), Patau syndrome (Trisomy 13), Edwards syndrome (Trisomy 18), and various sex chromosome anomalies that can impact an individual's development and health. The process involves analyzing a sample of blood or amniotic fluid to identify any extra or missing chromosomes or abnormalities in the structure of chromosomes 13, 18, 21, X, and Y. This test is significant for expectant parents or individuals seeking insight into their genetic health or reproductive risks. The cost for this comprehensive chromosomal test at DNA Labs UAE is 1950 AED, offering valuable information for early intervention and management of potential genetic conditions.
